Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide causes weight loss by slowing stomach emptying and reducing hunger signals in the brain, leading to sustained calorie deficit without constant willpower. Weekly weight loss rates typically range from 0.5 to 2 pounds once you reach an effective dose, though the first weeks may show less dramatic changes as your body adjusts. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, available in all 50 states without insurance or membership fees.
Typical Weekly Weight Loss Timeline on Semaglutide Therapy
During the first 2–4 weeks of semaglutide treatment, weight loss is often modest—typically 0.5 to 1 pound per week—as your body acclimates to the medication and doses remain in the ramp-up phase. Once you reach your maintenance dose (usually after 4–8 weeks), weekly loss often accelerates to 1–2 pounds as appetite suppression becomes consistent and pronounced. By month 3 and beyond, many patients experience sustained losses in this range, though individual results depend heavily on baseline weight, starting metabolic rate, and adherence to nutritional guidelines.
Clinical trials show that over 68 weeks, semaglutide users lose approximately 15–22% of body weight compared to 2–3% in placebo groups. This translates to roughly 30–50 pounds for a 200-pound person over the full treatment year, which averages 0.5–1 pound weekly over the longer term. Weight loss does not occur in a straight line; some weeks show no change while others reveal larger drops, a pattern driven by water retention, hormonal cycles, and metabolism adaptation.
Factors That Influence Your Weekly Weight Loss Rate
Starting weight is one of the strongest predictors of weekly loss—individuals with higher initial weight often shed more pounds per week in absolute terms, though percentage loss may be similar across body sizes. Adherence to a calorie-deficit diet amplifies semaglutide's effects; the medication reduces hunger but does not eliminate the need for mindful eating choices. Exercise frequency, sleep quality, stress levels, and insulin sensitivity all modulate how quickly your body mobilizes stored fat.
Genetic factors also play a significant role in weight loss responsiveness to GLP-1 therapy. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) identifies key variants in pathways controlling appetite, energy metabolism, and glucose handling—such as GLP1R rs6923761 and FTO rs9939609—that influence how effectively your body responds to semaglutide. Understanding your peptide-pathway genetics allows your provider to refine dosing and complement therapy with targeted lifestyle strategies.
Dose Adjustments and Weight Loss Plateaus on GLP-1 Injections
Semaglutide dosing begins low (0.25 mg weekly) and increases gradually every 4 weeks to minimize nausea and gastrointestinal side effects, with most patients reaching effective doses between 1–2 mg per week. PlexusDx offers compounded semaglutide injections starting at $149 per month—your dose may need to go up, but your price won't, ensuring affordability as your treatment advances. Weight loss typically continues as long as you remain below your body's natural set-point and maintain the calorie deficit that semaglutide enables.
Plateaus are normal and temporary; they reflect your body's metabolic adaptation and usually resolve within 2–4 weeks without additional intervention. Some patients benefit from dose increases within their prescribed range, while others find renewed progress through dietary adjustments or increased activity. If you experience prolonged stalling, your PlexusDx provider may recommend genetic testing or evaluate whether lifestyle factors—such as hidden calorie surplus or inadequate sleep—are limiting results.
Comparing Semaglutide to Other GLP-1 Options at PlexusDx
Semaglutide injection and oral semaglutide ($249/month) produce similar weight loss profiles, though injections typically offer better medication consistency and fewer gastrointestinal side effects due to higher bioavailability. For patients seeking dual-pathway activation, PlexusDx's GLP-Squared Injection ($249/month starting) combines compounded semaglutide and tirzepatide for enhanced appetite suppression and metabolic effects, though weekly loss rates average 0.5–1.5 pounds higher than semaglutide alone. Tirzepatide (a GIP/GLP-1 receptor agonist) may produce slightly faster initial loss, but the choice depends on your medical history, tolerance, and genetic predispositions revealed by the Precision Peptide Genetic Test.
PlexusDx also offers a Microdose GLP-1 Protocol at $129/month for patients seeking gentler entry to therapy or those with sensitivity to standard dosing. Realistic expectations matter: any GLP-1 medication requires consistency, supportive nutrition, and patience. Weekly fluctuations are normal, and sustainable loss—1–2 pounds per week over months—outperforms rapid crash approaches for long-term health and metabolism preservation.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose weight every single week on semaglutide?
No—weight loss is not linear. You may experience weeks with no change, followed by larger drops of 2–3 pounds. This pattern reflects water retention, hormonal shifts, and metabolism cycles. As long as your trend over 4 weeks is downward, therapy is working effectively.
What does clinical evidence say about semaglutide weight loss?
The STEP trials (spanning 68 weeks) showed semaglutide users lost 15–22% of baseline body weight versus 2–3% on placebo. For a 200-pound person, this means 30–50 pounds over one year, translating to approximately 0.5–1 pound weekly on average.
How much does PlexusDx semaglutide injection cost per month?
PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A compounding pharmacies, available in all 50 states without insurance or membership fees. Your dose may increase over time, but your monthly price remains flat.
Are there side effects that slow weight loss on semaglutide?
Nausea, vomiting, and constipation occur in some users during dose ramp-up but typically resolve within days to weeks. Severe gastrointestinal distress may reduce food intake beyond what's healthy; notify your provider if symptoms persist, as dose adjustment or medication changes may help.
Can the Precision Peptide Genetic Test predict my weight loss rate?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response to GLP-1 therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Eating Smart: How to Eat Like You’re on Ozempic for Lasting Wellness
Can GLP-1 Cause Depression? Understanding the Connection